SCHEMBL1678302

SCHEMBL1678302

CCCCCC([O])CCC

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
LCK P06239 1/20 0.44
PPARD Q03181 1/20 0.44
ZDHHC20 Q5W0Z9 1/20 0.44
ZDHHC2 Q9UIJ5 1/20 0.44
OPRM1 P35372 1/20 0.43
FDPS P14324 4/20 0.42
GPR84 Q9NQS5 3/20 0.41
CA1 P00915 2/20 0.41
FFAR1 O14842 1/20 0.41
LMNA P02545 1/20 0.40
ZDHHC7 Q9NXF8 1/20 0.40
MAPT P10636 1/20 0.39
TP53 P04637 1/20 0.39
LAP3 P28838 1/20 0.39
DNM1 Q05193 1/20 0.39
TSHR P16473 1/20 0.39
THRB P10828 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL77284 0.97 LCK (0.48) LCKPPARDZDHHC20ZDHHC2OPRM1
SCHEMBL27772339 0.97 LCK (0.48) LCKPPARDZDHHC20ZDHHC2OPRM1
SCHEMBL1879989 0.97 LCK (0.48) LCKPPARDZDHHC20ZDHHC2OPRM1
SCHEMBL79484 0.97 LCK (0.48) LCKPPARDZDHHC20ZDHHC2OPRM1
SCHEMBL6435205 0.97 LCK (0.48) LCKPPARDZDHHC20ZDHHC2OPRM1
SCHEMBL9177399 0.97 LCK (0.48) LCKPPARDZDHHC20ZDHHC2OPRM1
SCHEMBL76976 0.97 LCK (0.48) LCKPPARDZDHHC20ZDHHC2OPRM1
SCHEMBL11337707 0.97 LCK (0.48) LCKPPARDZDHHC20ZDHHC2OPRM1
SCHEMBL6433035 0.97 LCK (0.48) LCKPPARDZDHHC20ZDHHC2OPRM1
SCHEMBL3090884 0.94 LCK (0.48) LCKPPARDZDHHC20ZDHHC2OPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 65 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1119351-A2 USE OF CATECHOL DERIVATIVES AS PROTEINASE INHIBITORS Grünenthal GmbH (DE) 2001-08-01 EP claimed
WO-2000019989-A2 USE OF CATECHOL DERIVATIVES AS PROTEINASE INHIBITORS Grünenthal GmbH (DE) 2000-04-13 WO claimed
WO-2023223888-A1 METHOD FOR PRODUCING POLYCARBONATE RESIN, AND ALICYCLIC POLYCARBONATE RESIN 旭化成株式会社 2023-11-23 WO disclosed
CN-113490710-B Polycarbonate resin composition 帝人株式会社 2023-05-05 CN disclosed
US-20220049092-A1 POLYCARBONATE RESIN COMPOSITION TEIJIN LIMITED (JP) 2022-02-17 US disclosed
EP-3932981-A1 POLYCARBONATE RESIN COMPOSITION Teijin Limited (JP) 2022-01-05 EP disclosed
EP-3904443-A1 LIGHT-RESISTANT, HEAT-RESISTANT, AND DURABLE UV ABSORBENT Miyoshi Oil & Fat Co., Ltd. (JP) 2021-11-03 EP disclosed
CN-113195611-A Light-resistant, heat-resistant and durable ultraviolet absorber 三吉油脂株式会社 2021-07-30 CN disclosed
CN-112079862-A Carbonic acid ester liquid crystal intermediate and preparation method and application thereof 江苏创拓新材料有限公司 2020-12-15 CN disclosed
WO-2020137819-A1 LIGHT-RESISTANT, HEAT-RESISTANT, AND DURABLE UV ABSORBENT ミヨシ油脂株式会社 2020-07-02 WO disclosed
EP-3642252-A1 LATENT CURING AGENT AND CURABLE POLYURETHANE COMPOSITION Sika Technology AG (CH) 2020-04-29 EP disclosed
US-5416103-A N-cyclohex(en)yl-pyridine carboxamides and compositions containing them for controlling fungal pests BASF AKTIENGESELLSCHAFT (DE) 1995-05-16 US disclosed
EP-0632036-A2 Amide and urea derivatives having anti-hypercholesteremic activity, their preparation and their therapeutic uses SANKYO COMPANY LIMITED (JP) 1995-01-04 EP disclosed
EP-0591699-A1 N-hydroxy-N-phenylcarboxamides, processes for their production and agents containing them for the controlling of harmful fungi BASF Aktiengesellschaft (DE) 1994-04-13 EP disclosed
EP-0589313-A1 Cyclohex(en)ylcarboxamides, process for their preparation and anti-fungal agents containing them BASF Aktiengesellschaft (DE) 1994-03-30 EP disclosed
EP-0589301-A1 Carboxynilides derivatives, process for their preparation and fungicidal compositions containing them BASF Aktiengesellschaft (DE) 1994-03-30 EP disclosed
EP-0536936-A1 Pyrimidine nucleoside derivatives having anti-tumor activity, their preparation and use Sankyo Company Limited (JP) 1993-04-14 EP disclosed
EP-0416946-A2 Optically active naphthalene derivative, process for preparation thereof, liquid crystal composition containing the same as effective component, and liquid crystal element using the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1991-03-13 EP disclosed
US-4683244-A Sebosuppressive cosmetic preparations containing alkoxy or alkylbenzyloxy benzoic acids or their salts HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 1987-07-28 US disclosed
US-4319919-A 2,6-DINITRO-1-ALKOXYBENZENE KAKEN CHEMICAL CO., LTD. (JP) 1982-03-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220049092-A1 POLYCARBONATE RESIN COMPOSITION SULT1A1, RRS1, RPS24 LCK 4859/4885PPARD 2468/4885ZDHHC20 1797/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.